OpGen Highlights Strong Performance of Acuitas® Resistome Test at ASM Microbe 2016
GAITHERSBURG, Md., June 20, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, today presented data that support the use of its Acuitas® Resistome …